All siRNAs were purchased from Beijing Yibaike Co. Ltd., Beijing, China. To knock down TF and NOX2, the siRNA sequences were chosen as follows:
si-hTransferrin-1:5′-GUGUCUGGCUGUCCCUGAUAATT-3′,
si-hTransferrin-2:5′-CUUGAUCUGGGAGCUUCUCAATT-3′,
si-hNOX2-1:5′-GCUGUGCCUCAUAUUAAUUTT-3′,
si-hNOX2-2:5′- CCAUGGAGCUGAACGAAUUTT-3′.
The negative control was 5′-UUCUCCGAACGUGUCACGUdTdT3′.
Briefly, 143B cells were seeded in six-well plates at a density of 2 × 105 cells per well and transfected with siRNA using Lipofectamine-3000 reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. The cells were then incubated for two days, and the knockdown efficacy was validated using Western blot.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.